10-Q Filing

BEONE MEDICINES LTD. CIK: 1651308 Q3 2020

Filing Information

Form Type	10-Q
Accession Number	`0001651308-20-000208`
Period End Date	20200930
Filing Date	20201105
Fiscal Year	2020
Fiscal Period	Q3
XBRL Instance	bgne-20200930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 95 Income Statement 76 Cash Flow Statement 105 Stockholders Equity 51 Comprehensive Income 28

Balance Sheet 95 line items

Line Item	Tag	Value	Unit	Period
Ordinary shares, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Ordinary shares, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Ordinary shares, shares authorized (in shares)	`CommonStockSharesAuthorized`	9.50B	shares	Point-in-time
Ordinary shares, shares authorized (in shares)	`CommonStockSharesAuthorized`	9.50B	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$618.01M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$856.85M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.46B	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$295.00K	USD	Point-in-time
Ordinary shares, shares issued (in shares)	`CommonStockSharesIssued`	801.34M	shares	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$14.27M	USD	Point-in-time
Ordinary shares, shares issued (in shares)	`CommonStockSharesIssued`	1.18B	shares	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$288.00K	USD	Point-in-time
Short-term investments	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$3.25B	USD	Point-in-time
Short-term investments	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$364.73M	USD	Point-in-time
Ordinary shares, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.18B	shares	Point-in-time
Ordinary shares, shares outstanding (in shares)	`CommonStockSharesOutstanding`	801.34M	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$70.88M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$60.27M	USD	Point-in-time
Inventories	`InventoryNet`	$35.52M	USD	Point-in-time
Inventories	`InventoryNet`	$28.55M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$90.24M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$150.88M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$4.97B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.17B	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$4.95M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$2.48M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$30.40M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$291.22M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$242.40M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$88.69M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$82.52M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$5.19M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$5.85M	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$48.01M	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$37.89M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$68.45M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$162.60M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$600.65M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$439.59M	USD	Point-in-time
Total assets	`Assets`	$1.61B	USD	Point-in-time
Total assets	`Assets`	$5.57B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$122.49M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$146.26M	USD	Point-in-time
Accrued expenses and other payables	`AccruedLiabilitiesCurrent`	$279.32M	USD	Point-in-time
Accrued expenses and other payables	`AccruedLiabilitiesCurrent`	$163.56M	USD	Point-in-time
Tax payable	`TaxesPayableCurrent`	$13.45M	USD	Point-in-time
Tax payable	`TaxesPayableCurrent`	$9.24M	USD	Point-in-time
Operating lease liabilities, current portion	`OperatingLeaseLiabilityCurrent`	$13.28M	USD	Point-in-time
Operating lease liabilities, current portion	`OperatingLeaseLiabilityCurrent`	$10.81M	USD	Point-in-time
Research and development cost share liability, current portion	`ResearchAndDevelopmentCostShareLiabilityCurrentPortion`	$147.39M	USD	Point-in-time
Research and development cost share liability, current portion	`ResearchAndDevelopmentCostShareLiabilityCurrentPortion`	-	USD	Point-in-time
Short-term debt	`LongTermDebtCurrent`	-	USD	Point-in-time
Short-term debt	`LongTermDebtCurrent`	$50.22M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$645.72M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$310.31M	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$83.31M	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$151.55M	USD	Point-in-time
Shareholder loan	`DueToRelatedPartiesNoncurrent`	$157.38M	USD	Point-in-time
Shareholder loan	`DueToRelatedPartiesNoncurrent`	-	USD	Point-in-time
Operating lease liabilities, non-current portion	`OperatingLeaseLiabilityNoncurrent`	$28.68M	USD	Point-in-time
Operating lease liabilities, non-current portion	`OperatingLeaseLiabilityNoncurrent`	$25.83M	USD	Point-in-time
Deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$10.53M	USD	Point-in-time
Deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$11.88M	USD	Point-in-time
Research and development cost share liability, non-current portion	`ResearchAndDevelopmentCostShareLiabilityNoncurrentPortion`	$384.15M	USD	Point-in-time
Research and development cost share liability, non-current portion	`ResearchAndDevelopmentCostShareLiabilityNoncurrentPortion`	-	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$47.89M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$46.56M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$323.62M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$624.15M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.27B	USD	Point-in-time
Total liabilities	`Liabilities`	$633.93M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Ordinary shares, US$0.0001 par value per share; 9,500,000,000 shares authorized; 1,182,916,659 and 801,340,698 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively	`CommonStockValue`	$79.00K	USD	Point-in-time
Ordinary shares, US$0.0001 par value per share; 9,500,000,000 shares authorized; 1,182,916,659 and 801,340,698 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively	`CommonStockValue`	$118.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$7.37B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$2.93B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-419.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-8.00M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-3.08B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.96B	USD	Point-in-time
Total BeiGene, Ltd. shareholders equity	`StockholdersEquity`	$4.29B	USD	Point-in-time
Total BeiGene, Ltd. shareholders equity	`StockholdersEquity`	$962.21M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$16.15M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$9.02M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.55B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.62B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.75B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.29B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.30B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.83B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$978.36M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.57B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$1.61B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$5.57B	USD	Point-in-time

Income Statement 76 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$91.08M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$208.77M	USD	3 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$50.14M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$371.32M	USD	3 Qtrs
Cost of sales - product	`CostOfGoodsAndServicesSold`	$53.21M	USD	3 Qtrs
Cost of sales - product	`CostOfGoodsAndServicesSold`	$20.11M	USD	1 Quarter
Cost of sales - product	`CostOfGoodsAndServicesSold`	$21.12M	USD	1 Quarter
Cost of sales - product	`CostOfGoodsAndServicesSold`	$49.58M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$349.07M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$644.08M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$939.34M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$236.97M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$391.97M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$244.90M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$160.84M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$105.00M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$994.00K	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$331.00K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$658.00K	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$187.00K	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$362.41M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$1.38B	USD	3 Qtrs
Total expenses	`CostsAndExpenses`	$531.22M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$943.17M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-1.17B	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-571.85M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-312.27M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-440.14M	USD	1 Quarter
Interest (expense) income, net	`InterestIncomeExpenseNet`	$2.21M	USD	1 Quarter
Interest (expense) income, net	`InterestIncomeExpenseNet`	$7.18M	USD	3 Qtrs
Interest (expense) income, net	`InterestIncomeExpenseNet`	$9.57M	USD	3 Qtrs
Interest (expense) income, net	`InterestIncomeExpenseNet`	$-614.00K	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$29.37M	USD	3 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-1.82M	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$5.71M	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-967.00K	USD	3 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-311.88M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-435.04M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-1.14B	USD	3 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-563.25M	USD	3 Qtrs
Income tax benefit	`IncomeTaxExpenseBenefit`	$-569.00K	USD	3 Qtrs
Income tax benefit	`IncomeTaxExpenseBenefit`	$-3.22M	USD	1 Quarter
Income tax benefit	`IncomeTaxExpenseBenefit`	$-8.34M	USD	3 Qtrs
Income tax benefit	`IncomeTaxExpenseBenefit`	$-8.42M	USD	1 Quarter
Net loss	`ProfitLoss`	$-85.95M	USD	1 Quarter
Net loss	`ProfitLoss`	$-168.07M	USD	1 Quarter
Net loss	`ProfitLoss`	$-336.32M	USD	1 Quarter
Net loss	`ProfitLoss`	$-308.66M	USD	1 Quarter
Net loss	`ProfitLoss`	$-364.94M	USD	1 Quarter
Net loss	`ProfitLoss`	$-426.62M	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.13B	USD	3 Qtrs
Net loss	`ProfitLoss`	$-562.68M	USD	3 Qtrs
Less: net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-2.12M	USD	3 Qtrs
Less: net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.30M	USD	1 Quarter
Less: net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.39M	USD	1 Quarter
Less: net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-3.71M	USD	3 Qtrs
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-425.22M	USD	1 Quarter
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-560.57M	USD	3 Qtrs
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-307.36M	USD	1 Quarter
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-1.12B	USD	3 Qtrs
Net loss per share attributable to BeiGene, Ltd., basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.72	USD	3 Qtrs
Net loss per share attributable to BeiGene, Ltd., basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.39	USD	1 Quarter
Net loss per share attributable to BeiGene, Ltd., basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-1.07	USD	3 Qtrs
Net loss per share attributable to BeiGene, Ltd., basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.37	USD	1 Quarter
Weighted-average shares outstanding, basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	1.05B	shares	3 Qtrs
Weighted-average shares outstanding, basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	1.15B	shares	1 Quarter
Weighted-average shares outstanding, basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	777.94M	shares	3 Qtrs
Weighted-average shares outstanding, basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	781.48M	shares	1 Quarter
Net loss per American Depositary Share (ADS), basic and diluted (in dollars per share)	`EarningsPerAmericanDepositoryShare`	$-9.37	USD	3 Qtrs
Net loss per American Depositary Share (ADS), basic and diluted (in dollars per share)	`EarningsPerAmericanDepositoryShare`	$-5.11	USD	1 Quarter
Net loss per American Depositary Share (ADS), basic and diluted (in dollars per share)	`EarningsPerAmericanDepositoryShare`	$-13.88	USD	3 Qtrs
Net loss per American Depositary Share (ADS), basic and diluted (in dollars per share)	`EarningsPerAmericanDepositoryShare`	$-4.81	USD	1 Quarter
Weighted-average ADSs outstanding, basic and diluted (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstanding`	60.11M	shares	1 Quarter
Weighted-average ADSs outstanding, basic and diluted (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstanding`	59.84M	shares	3 Qtrs
Weighted-average ADSs outstanding, basic and diluted (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstanding`	81.00M	shares	3 Qtrs
Weighted-average ADSs outstanding, basic and diluted (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstanding`	88.38M	shares	1 Quarter

Cash Flow Statement 105 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-85.95M	USD	1 Quarter
Net loss	`ProfitLoss`	$-168.07M	USD	1 Quarter
Net loss	`ProfitLoss`	$-336.32M	USD	1 Quarter
Net loss	`ProfitLoss`	$-308.66M	USD	1 Quarter
Net loss	`ProfitLoss`	$-364.94M	USD	1 Quarter
Net loss	`ProfitLoss`	$-426.62M	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.13B	USD	3 Qtrs
Net loss	`ProfitLoss`	$-562.68M	USD	3 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$23.96M	USD	3 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$11.13M	USD	3 Qtrs
Share-based compensation expenses	`ShareBasedCompensation`	$95.81M	USD	3 Qtrs
Share-based compensation expenses	`ShareBasedCompensation`	$134.02M	USD	3 Qtrs
Unrealized gains on equity method investments	`UnrealizedGainLossOnInvestments`	$9.97M	USD	3 Qtrs
Unrealized gains on equity method investments	`UnrealizedGainLossOnInvestments`	-	USD	3 Qtrs
Gain on deconsolidation of a subsidiary	`DeconsolidationGainOrLossAmount`	$11.31M	USD	3 Qtrs
Gain on deconsolidation of a subsidiary	`DeconsolidationGainOrLossAmount`	-	USD	3 Qtrs
Acquired in-process research and development	`AcquiredInProcessResearchAndDevelopment`	$49.00M	USD	3 Qtrs
Acquired in-process research and development	`AcquiredInProcessResearchAndDevelopment`	$89.50M	USD	3 Qtrs
Amortization of research and development cost share liability	`AmortizationofResearchAndDevelopmentFinancingLiability`	-	USD	3 Qtrs
Amortization of research and development cost share liability	`AmortizationofResearchAndDevelopmentFinancingLiability`	$-85.30M	USD	3 Qtrs
Deferred income tax benefits	`DeferredIncomeTaxesAndTaxCredits`	$-8.76M	USD	3 Qtrs
Deferred income tax benefits	`DeferredIncomeTaxesAndTaxCredits`	$-13.33M	USD	3 Qtrs
Other items, net	`OtherOperatingActivitiesCashFlowStatement`	$-2.73M	USD	3 Qtrs
Other items, net	`OtherOperatingActivitiesCashFlowStatement`	$1.14M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$14.86M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-10.50M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$21.27M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$6.97M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$5.65M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$52.94M	USD	3 Qtrs
Operating lease right-of-use assets	`IncreaseDecreaseInOperatingLeaseRightofUseAsset`	$5.21M	USD	3 Qtrs
Operating lease right-of-use assets	`IncreaseDecreaseInOperatingLeaseRightofUseAsset`	$4.30M	USD	3 Qtrs
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$15.31M	USD	3 Qtrs
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$5.98M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-8.15M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$21.98M	USD	3 Qtrs
Accrued expenses and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$115.87M	USD	3 Qtrs
Accrued expenses and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$33.49M	USD	3 Qtrs
Tax payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-12.27M	USD	3 Qtrs
Tax payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$3.17M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	-	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-27.98M	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$5.31M	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$2.07M	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-1.50M	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-26.83M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-483.09M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-951.13M	USD	3 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$82.82M	USD	3 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$74.15M	USD	3 Qtrs
Deconsolidation of a subsidiary	`CashDivestedFromDeconsolidation`	-	USD	3 Qtrs
Deconsolidation of a subsidiary	`CashDivestedFromDeconsolidation`	$2.02M	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$4.88B	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$850.83M	USD	3 Qtrs
Proceeds from sale or maturity of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$1.55B	USD	3 Qtrs
Proceeds from sale or maturity of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$1.97B	USD	3 Qtrs
Purchase of in-process research and development	`PaymentsToPurchaseInProcessResearchAndDevelopment`	$89.50M	USD	3 Qtrs
Purchase of in-process research and development	`PaymentsToPurchaseInProcessResearchAndDevelopment`	$49.00M	USD	3 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$578.05M	USD	3 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-3.08B	USD	3 Qtrs
Proceeds from sale of ordinary shares, net of cost	`ProceedsFromIssuanceOfCommonStockNetOfUnderwriterDiscount`	-	USD	3 Qtrs
Proceeds from sale of ordinary shares, net of cost	`ProceedsFromIssuanceOfCommonStockNetOfUnderwriterDiscount`	$4.23B	USD	3 Qtrs
Proceeds from research and development cost share liability	`ProceedsFromResearchAndDevelopmentFinancingLiability`	$616.83M	USD	3 Qtrs
Proceeds from research and development cost share liability	`ProceedsFromResearchAndDevelopmentFinancingLiability`	-	USD	3 Qtrs
Capital contribution from noncontrolling interest	`ProceedsFromMinorityShareholders`	$4.00M	USD	3 Qtrs
Capital contribution from noncontrolling interest	`ProceedsFromMinorityShareholders`	-	USD	3 Qtrs
Prepayment to acquire joint venture ("JV") minority interest	`PaymentsToAcquireInterestInJointVentureFinancingActivities`	-	USD	3 Qtrs
Prepayment to acquire joint venture ("JV") minority interest	`PaymentsToAcquireInterestInJointVentureFinancingActivities`	$28.72M	USD	3 Qtrs
Proceeds from long-term loans	`ProceedsFromLongTermLinesOfCredit`	$64.29M	USD	3 Qtrs
Proceeds from long-term loans	`ProceedsFromLongTermLinesOfCredit`	$67.49M	USD	3 Qtrs
Repayment of long-term loans	`RepaymentsOfLongTermDebt`	$8.39M	USD	3 Qtrs
Repayment of long-term loans	`RepaymentsOfLongTermDebt`	$132.06M	USD	3 Qtrs
Proceeds from short-term loans	`ProceedsFromShortTermDebt`	-	USD	3 Qtrs
Proceeds from short-term loans	`ProceedsFromShortTermDebt`	$48.98M	USD	3 Qtrs
Proceeds from option exercises and employee share purchase plan	`ProceedsFromStockOptionsExercised`	$20.39M	USD	3 Qtrs
Proceeds from option exercises and employee share purchase plan	`ProceedsFromStockOptionsExercised`	$75.83M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$83.48M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.88B	USD	3 Qtrs
Effect of foreign exchange rate changes, net	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-18.34M	USD	3 Qtrs
Effect of foreign exchange rate changes, net	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.34M	USD	3 Qtrs
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$160.11M	USD	3 Qtrs
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$848.94M	USD	3 Qtrs
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$900.82M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.47B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$740.71M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$620.77M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$900.82M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.47B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$740.71M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$620.77M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$618.01M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$856.85M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.46B	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$295.00K	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$14.27M	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$288.00K	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$4.95M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$2.48M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$30.40M	USD	Point-in-time
Income taxes paid	`IncomeTaxesPaidNet`	$8.95M	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$10.60M	USD	3 Qtrs
Interest paid	`InterestPaidNet`	$41.58M	USD	3 Qtrs
Interest paid	`InterestPaidNet`	$3.33M	USD	3 Qtrs
Acquisitions of equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$30.93M	USD	3 Qtrs
Acquisitions of equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$29.25M	USD	3 Qtrs

Stockholders Equity 51 line items

Line Item	Tag	Value	Unit	Period
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.55B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.62B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.75B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.29B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.30B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.83B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$978.36M	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.57B	USD	Point-in-time
Balance at the beginning of period (in shares)	`CommonStockSharesOutstanding`	1.18B	shares	Point-in-time
Balance at the beginning of period (in shares)	`CommonStockSharesOutstanding`	801.34M	shares	Point-in-time
Issuance of ordinary shares in connection with collaboration	`StockIssuedDuringPeriodValueNewIssues`	$2.16B	USD	1 Quarter
Issuance of ordinary shares in connection with collaboration	`StockIssuedDuringPeriodValueNewIssues`	$2.07B	USD	1 Quarter
Issuance of shares reserved for share option exercises	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$1.00K	USD	1 Quarter
Contributions from shareholders	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$4.00M	USD	1 Quarter
Exercise of options, ESPP and release of Restricted Share Units (RSUs)	`StockIssuedDuringPeriodValueStockOptionsExercised`	$9.74M	USD	1 Quarter
Exercise of options, ESPP and release of Restricted Share Units (RSUs)	`StockIssuedDuringPeriodValueStockOptionsExercised`	$4.37M	USD	1 Quarter
Exercise of options, ESPP and release of Restricted Share Units (RSUs)	`StockIssuedDuringPeriodValueStockOptionsExercised`	$6.27M	USD	1 Quarter
Exercise of options, ESPP and release of Restricted Share Units (RSUs)	`StockIssuedDuringPeriodValueStockOptionsExercised`	$47.63M	USD	1 Quarter
Exercise of options, ESPP and release of Restricted Share Units (RSUs)	`StockIssuedDuringPeriodValueStockOptionsExercised`	$11.63M	USD	1 Quarter
Exercise of options, ESPP and release of Restricted Share Units (RSUs)	`StockIssuedDuringPeriodValueStockOptionsExercised`	$16.57M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$32.60M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$38.26M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$36.82M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$26.39M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$50.30M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$45.47M	USD	1 Quarter
Deconsolidation of a subsidiary	`NoncontrollingInterestDecreaseFromDeconsolidation`	$3.54M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$4.44M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$1.35M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-2.74M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-6.44M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-14.93M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$9.10M	USD	1 Quarter
Net loss	`ProfitLoss`	$-85.95M	USD	1 Quarter
Net loss	`ProfitLoss`	$-168.07M	USD	1 Quarter
Net loss	`ProfitLoss`	$-336.32M	USD	1 Quarter
Net loss	`ProfitLoss`	$-308.66M	USD	1 Quarter
Net loss	`ProfitLoss`	$-364.94M	USD	1 Quarter
Net loss	`ProfitLoss`	$-426.62M	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.13B	USD	3 Qtrs
Net loss	`ProfitLoss`	$-562.68M	USD	3 Qtrs
Balance at the ending of period (in shares)	`CommonStockSharesOutstanding`	1.18B	shares	Point-in-time
Balance at the ending of period (in shares)	`CommonStockSharesOutstanding`	801.34M	shares	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.55B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.62B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.75B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.29B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.30B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.83B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$978.36M	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.57B	USD	Point-in-time

Comprehensive Income 28 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-85.95M	USD	1 Quarter
Net loss	`ProfitLoss`	$-168.07M	USD	1 Quarter
Net loss	`ProfitLoss`	$-336.32M	USD	1 Quarter
Net loss	`ProfitLoss`	$-308.66M	USD	1 Quarter
Net loss	`ProfitLoss`	$-364.94M	USD	1 Quarter
Net loss	`ProfitLoss`	$-426.62M	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.13B	USD	3 Qtrs
Net loss	`ProfitLoss`	$-562.68M	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$7.53M	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-13.67M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$10.14M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-17.25M	USD	3 Qtrs
Unrealized holding (loss) gain, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-1.04M	USD	1 Quarter
Unrealized holding (loss) gain, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-1.26M	USD	1 Quarter
Unrealized holding (loss) gain, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$184.00K	USD	3 Qtrs
Unrealized holding (loss) gain, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$326.00K	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-1.12B	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-323.59M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-417.52M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-579.61M	USD	3 Qtrs
Less: comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-1.63M	USD	1 Quarter
Less: comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-3.58M	USD	3 Qtrs
Less: comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-1.17M	USD	1 Quarter
Less: comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-2.69M	USD	3 Qtrs
Comprehensive loss attributable to BeiGene, Ltd.	`ComprehensiveIncomeNetOfTax`	$-1.12B	USD	3 Qtrs
Comprehensive loss attributable to BeiGene, Ltd.	`ComprehensiveIncomeNetOfTax`	$-576.92M	USD	3 Qtrs
Comprehensive loss attributable to BeiGene, Ltd.	`ComprehensiveIncomeNetOfTax`	$-416.34M	USD	1 Quarter
Comprehensive loss attributable to BeiGene, Ltd.	`ComprehensiveIncomeNetOfTax`	$-321.96M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.